US-12626800-B2 - Telemetric dosage controller system

US12626800B2US 12626800 B2US12626800 B2US 12626800B2US-12626800-B2

Abstract

The disclosed telemetric control system comprises: at least one activatable member configured to be actuated upon administration of a medication thereby triggering an actuation event of the system that initiates electronic tracking of a medication administration event; a signal transmitter operatively coupled to the at least one activatable member and which is configured to transmit or receive data signals via at least one wireless network; one or more non-transitory memory devices storing control logic customized to the identifier data associated with the electronic health record of the first biological system; and a powering mechanism configured to supply energy to components of the telemetric control system. It is appreciated that actuating the at least one activatable member triggers the signal transmitter to securely transmit encrypted data to a server for substantially real-time monitoring, automated alert generation, and adherence management associated with at least a medication.

Inventors

Richard S. KOPLIN
Kari Thorstensen
Geoff Scott

Assignees

Eye Thena, Inc.

Dates

Publication Date: 20260512
Application Date: 20251010

Claims (20)

1 . A telemetric control system for improving medication adherence through substantially real-time dosage tracking and medication delivery management, the telemetric control system comprising: at least one activatable member configured to be actuated upon administration of a first medication thereby triggering an actuation event of the telemetric control system that initiates electronic tracking of a medication administration event associated with the first medication, the medication administration event representing a delivery of the first medication to a first biological system; a signal transmitter operatively coupled to the at least one activatable member and configured to transmit or receive data signals via at least one wireless network, wherein the signal transmitter relays one or more of: timestamp data associated with the actuation event, dosage verification data associated with the first medication, and identifier data associated with an electronic health record (EHR) of the first biological system; one or more non-transitory memory devices storing control logic customized to the identifier data associated with the EHR of the first biological system, the control logic being configured to implement one or more of: correlating or mapping the actuation event with dosage parameters including: a drug type parameter associated with the first medication, dosage quanta data associated with delivery of the first medication to the first biological system, and delivery interval data associated with a first temporal window between a first delivery of the first medication to the first biological system, and a second delivery of the first medication to the first biological system, and dynamically adjusting the dosage parameters based on one or more of: physiological or biomarker data associated with delivery of: the first medication to the first biological system, or a second medication; response data associated with: a first detected effect of the first medication on the first biological system, a second detected effect of a second medication on the first biological system, or a third detected effect of a third medication on the first biological system or a second biological system; a powering mechanism configured to supply energy to components of the telemetric control system, the powering mechanism including at least one of: a rechargeable battery system coupled to, or integrated into the telemetric control system, a disposable battery system configured to power the telemetric control system for a second temporal window, a wireless charging energy system configured to wirelessly charge or power the telemetric control system, or an energy harvesting system configured to use kinetic energy, thermoelectric energy, or vibrational energy associated with the first biological system; and wherein actuating the at least one activatable member triggers the signal transmitter to securely transmit encrypted data to a server for substantially real-time monitoring, automated alert generation, and adherence management associated with at least the first medication.
2 . The telemetric control system of claim 1 , wherein the at least one activatable member comprises a button or touch-sensitive interface directly coupled to a medication container or positioned proximal thereto, the coupling achieved via an adjustable band configured to fit around varying container diameters including a first diameter of a container within which is the first medication.
3 . The telemetric control system of claim 2 , wherein the at least one activatable member is coupled to the medication container via: an elastic band fabricated from silicone or latex-free materials, the elastic band being structured to: stretch and thereby conform to a container contour of a container within which is placed the first medication, and incorporate an anti-slip texture for stabilizing the elastic band around the container, or a Velcro-based fastening system comprising hook-and-loop strips, allowing reusable and repositionable attachment with or without magnetic assistance for one-handed operation of the telemetric control system.
4 . The telemetric control system of claim 2 , wherein the at least one activatable member is coupled via adhesive means, such as pressure-sensitive adhesives or medical-grade epoxies with residue-free removal, combined with tamper-detection sensors to alert the control logic stored in the one or more non-transitory memory devices, of unauthorized removal attempts.
5 . The telemetric control system of claim 1 , wherein the control logic is further configured to generate, or initiate generation of a multidimensional report including: medication adherence data associated with delivering to the first biological system, the first medication or the second medication, pharmacokinetic adherence curve data indicating an assessment or prediction of how closely a medication regimen of the first medication or the second medication is observed by the first biological system, and predictive analytics data based on historical actuation patterns of the at least the one activatable member.
6 . The telemetric control system of claim 5 , wherein: the multidimensional report comprises multi-modal data including visual timelines, interactive charts, and audio summaries, the multidimensional report comprises: timestamp data of delivering at least the first medication to the first biological system within the first temporal window, the second temporal window, or a third temporal window, dosage quanta data associated with delivering the first medication to the first biological system during the first temporal window, the second temporal window, or the third temporal window, and deviation data associated with inconsistent delivery of the first medication to the first biological system over the first temporal window, the second temporal window, or the third temporal window, and the multidimensional report being configured to be visualized on a display computing device in one of a Portable Document Format (PDF) file format, a Comma-Separated Values (CSV) file format, a data format associated with textual data or video data or audiovisual data.
7 . The telemetric control system of claim 5 , wherein: the telemetric control system further comprises an interface for bidirectional integration with an EHR system that is compliant with a Health Level Seven International (HL7) Fast Healthcare Interoperability Resources (FHIR) standards, the multidimensional report comprises: cumulative adherence rate data indicating delivering at least the first medication to the first biological system, anomaly detection data indicating unexpected dosage variations associated with delivering at least the first medication to the first biological system, and machine learning-based risk prediction data associated with optimizing delivery of at least the first medication to the first biological system.
8 . The telemetric control system of claim 5 , wherein the multidimensional report includes a substantially real-time inventory depletion forecast generated, based on actuating the at least one activatable member, the inventory depletion forecast indicating one or more of: a time for replenishing the first medication, and a quantity of the first medication to be replenished.
9 . The telemetric control system of claim 1 , further comprising one or more sensor arrays interfaced with the signal transmitter for acquiring physiological data of the first biological system such as biomarker levels or vital signs of the first biological system, enabling a closed-loop feedback mechanism that informs the control logic to dynamically adjust dosage quanta or delivery intervals of delivering the first medication to the first biological system.
10 . The telemetric control system of claim 1 , wherein the telemetric control system is configured to facilitate remote prescription submission by automatically triggering refill requests to a linked pharmacy or an EHR system based on activating the at least one activatable member.
11 . The telemetric control system of claim 1 , wherein the signal transmitter supports over-the-air (OTA) firmware updates to the one or more non-transitory memory devices of the telemetric control system and transmission of user-specific feedback, including aggregated actuation logs and adherence metrics, to healthcare providers for adjusting a medication regimen of the first medication relative to the first biological system.
12 . The telemetric control system of claim 1 , wherein telemetric control system comprises: a first activatable member of the at least one activatable member which is activatable to track the first medication, a second activatable member of the at least one activatable member which is activatable to track the second medication, and a third activatable member of the at least one activatable member which is activatable to track a third medication.
13 . The telemetric control system of claim 1 , wherein the powering mechanism comprises a rechargeable lithium-ion battery with USB charging via a USB-A or micro-USB port, including a power management module that regulates charging cycles and optimize energy distribution for low-power operations between actuations of the at least one activatable member.
14 . The telemetric control system of claim 1 , wherein the powering mechanism comprises a USB-C port supporting Power Delivery (PD) standards for faster charging and simultaneous data transfer during firmware updates or EHR synchronization.
15 . The telemetric control system of claim 1 , wherein the disposable battery system of the powering mechanism comprises one of a coin-cell or alkaline battery, coin cel or alkaline battery being housed in an accessible compartment of the telemetric control system and optimized for ultra-low power consumption through power saving modes that deactivate non-essential components from drawing energy from the powering mechanism during non-medication delivery times associated with the first medication.
16 . The telemetric control system of claim 1 , wherein the wireless charging energy system of the powering mechanism comprises wireless charging via a Qi-standard inductive charging with an embedded coil, allowing cable-free energy transfer to the telemetric control system and supporting sealed, water-resistant designs of the telemetric control system for enhanced durability in clinical or non-critical environments.
17 . The telemetric control system of claim 1 , the energy harvesting system is configured to generate energy for the telemetric control system based on one or more: a piezoelectric generator embedded in the at least one activatable member, such that the piezoelectric generator converts mechanical energy from actuations of the at least one activatable member into electrical energy that powers the telemetric control system, or a photovoltaic cell for capturing and converting ambient light into electrical energy that powers the telemetric control system.
18 . The telemetric control system of claim 1 , wherein the powering mechanism comprises a hybrid system with a primary rechargeable battery and a secondary disposable battery for failover, the control logic being configured to monitor battery levels and switching energy sources to maintain uninterrupted operation of the telemetric control system during power disruptions.
19 . The telemetric control system of claim 1 , wherein the telemetric control system is configured for interoperability with Internet of Things (IoT) ecosystems, such that the signal transmitter communicates with external devices to contextualize dosage decisions based on environmental data, and blockchain technology for immutable logging of actuation events to ensure tamper-proof audit trails.
20 . The telemetric control system of claim 1 , wherein the at least one wireless network is selected from a group consisting a Bluetooth Low Energy (BTLE) network, a Wi-Fi network, a satellite communications network, or a cellular network.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS This application claims priority to, and benefit of U.S. Provisional Patent App. No. 63/706,168, filed on Oct. 11, 2024, and titled “Medication Tracking Device,” which is incorporated herein by reference in its entirety for all purposes. FIELD OF DISCLOSURE The present disclosure is directed to a telemetric system for managing medication delivery to biological systems. BACKGROUND There is a need for systems and methods that track, monitor, and inform the delivery of medications to biological systems. SUMMARY The disclosed telemetric control system is configured for improving medication adherence through substantially real-time dosage tracking and medication delivery management. According to one embodiment, the telemetric control system comprises: at least one activatable member configured to be actuated upon administration of a first medication thereby triggering an actuation event of the system that initiates electronic tracking of a medication administration event associated with the first medication. It is appreciated that the medication administration event represents a delivery of the first medication to a first biological system (e.g., a patient). The telemetric control system can also include a signal transmitter operatively coupled to the at least one activatable member and which is configured to transmit or receive data signals via at least one wireless network. According to one embodiment, the signal transmitter relays one or more of: timestamp data associated with the actuation event; dosage verification data associated with the first medication; and identifier data associated with an electronic health record (EHR) of the first biological system. The telemetric control system can also comprise one or more non-transitory memory devices storing control logic customized to the identifier data associated with the electronic health record of the first biological system. In one embodiment, customizing the control logic to identifier data associated with the EHR involves adapting the telemetric control system's control logic and operational parameters to the attributes of a specific biological system, as identified by data such as the name of the biological system, medical record information of the biological system, or other identifiers within the EHR. This customization ensures that the telemetric control system's functions—such as tracking medication administration events, correlating dosage parameters, and adjusting delivery schedules—are personalized to the specific medical profile of the biological system, including their prescribed medications, health conditions, and treatment plans. For instance, the control logic may map actuation events to the patient's drug type, dosage quanta, and delivery intervals as recorded in the EHR, while also integrating physiological feedback or patient-reported outcomes specific to that biological system. By leveraging identifier data, the telemetric control system ensures accurate, patient-specific monitoring and management, enhancing medication adherence and minimizing risks in complex scenarios like polypharmacy, while maintaining compliance with healthcare standards. According to one embodiment, the control logic is configured to: correlate or map the actuation event with dosage parameters including: a drug type parameter associated with the first medication; dosage quanta data associated with delivery of the first medication to the first biological system; and delivery interval data associated with a first temporal window between a first delivery of the first medication to the first biological system, and a second delivery of the first medication to the first biological system; and dynamically adjusting the dosage parameters based on physiological or biomarker data associated with delivery of the first medication to the first biological system, or a second medication. Dynamically adjusting the dosage parameters can also be based on response data associated with: a first detected effect of the first medication on the first biological system; a second detected effect of a second medication on the first biological system; or a third detected effect of a third medication on the first biological system or a second biological system. The disclosed telemetric control system comprises a powering mechanism configured to supply energy to components of the telemetric control system, the powering mechanism including at least one of: a rechargeable battery system coupled to, or integrated into the telemetric control system; a disposable battery system configured to power the telemetric control system for a second temporal window; a wireless charging energy system configured to wirelessly charge or power the telemetric control system; or an energy harvesting system configured to use kinetic energy, thermoelectric energy, or vibrational energy associated with the first biological system. It is appreciated that actuating the at least on